Literature DB >> 8137938

Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2.

P Loetscher1, M Seitz, I Clark-Lewis, M Baggiolini, B Moser.   

Abstract

Neutrophil leukocytes, the target cells for interleukin-8 and related CXC chemokines, bear high numbers of two types of IL-8 receptors (IL-8R1 and IL-8R2). By cDNA transfection Jurkat cell lines were generated that stably express either IL-8R1 or IL-8R2 (J-IL8R1 and J-IL8R2). J-IL8R1 expressed 4,000 +/- 1,000 copies of IL-8R1, and bound IL-8 with high affinity (Kd 1-4 nM) and GRO alpha and NAP-2 with low affinity (Kd 200-500 nM). J-IL8R2 expressed 17,000 +/- 3,000 copies of IL-8R2, and bound all three chemokines with high affinity. Both transfectants showed a similar degree of chemotactic migration after stimulation with IL-8, GRO alpha and NAP-2. All three chemokines were equally potent as attractants of J-IL8R2, whereas IL-8 was 300 to 1,000-fold more potent than GRO alpha or NAP-2 as attractant of J-IL8R1. The potencies, therefore, agree with the affinities of the ligands to IL-8R1 and IL-8R2. Our results demonstrate that both IL-8 receptors function independently, and mediate chemotaxis in response to IL-8 and other CXC chemokines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137938     DOI: 10.1016/0014-5793(94)80454-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha.

Authors:  D A Hall; I J Beresford; C Browning; H Giles
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.

Authors:  S A Jones; M Wolf; S Qin; C R Mackay; M Baggiolini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 3.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

4.  The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.

Authors:  Hans R Lüttichau
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

5.  The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis.

Authors:  Paige J Baugher; Ann Richmond
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

Review 6.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

7.  CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.

Authors:  W C Tsai; R M Strieter; B Mehrad; M W Newstead; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

8.  Synergistic interactions between chemokine receptor elements in recognition of interleukin-8 by soluble receptor mimics.

Authors:  Emily F Barter; Martin J Stone
Journal:  Biochemistry       Date:  2012-01-30       Impact factor: 3.162

9.  Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.

Authors:  Jiaoti Huang; Jorge L Yao; Li Zhang; Patricia A Bourne; Andrew M Quinn; P Anthony di Sant'Agnese; Jay E Reeder
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

10.  Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis.

Authors:  Guo-Huang Fan; Lynne A Lapierre; James R Goldenring; Jiqing Sai; Ann Richmond
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.